ProfileGDS4718 / 207658_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 45% 45% 41% 46% 46% 44% 42% 41% 54% 42% 44% 45% 46% 45% 45% 38% 44% 43% 38% 46% 36% 40% 46% 43% 43% 44% 43% 43% 40% 41% 45% 40% 44% 42% 42% 40% 42% 45% 42% 43% 40% 42% 43% 39% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.261645
GSM549102patient 115, normal, homogenized [OPG study]5.277845
GSM549104patient 119, normal, homogenized [OPG study]5.0373141
GSM549108patient 138, normal, homogenized [OPG study]5.3376146
GSM549119patient 077, normal, homogenized [OPG study]5.3316146
GSM549133patient 032, cancer, homogenized [OPG study]5.1508644
GSM549139patient 042, cancer, homogenized [OPG study]5.0771342
GSM549099patient 107, normal, homogenized [OPG study]5.0415741
GSM549109patient 139, normal, homogenized [OPG study]5.7439454
GSM549110patient 046, normal, homogenized [OPG study]5.0731842
GSM549114patient 063, normal, homogenized [OPG study]5.1604644
GSM549122patient 082, normal, homogenized [OPG study]5.2538945
GSM549134patient 033, cancer, homogenized [OPG study]5.2740946
GSM549136patient 036, cancer, homogenized [OPG study]5.1930945
GSM549140patient 044, cancer, homogenized [OPG study]5.1804145
GSM549111patient 047, normal, homogenized [OPG study]4.8653738
GSM549113patient 057, normal, homogenized [OPG study]5.1149444
GSM549132patient 031, cancer, homogenized [OPG study]5.1069743
GSM549137patient 038, cancer, homogenized [OPG study]4.8676238
GSM549142patient 047, cancer, homogenized [OPG study]5.4400846
GSM549100patient 110, normal, homogenized [OPG study]4.8424436
GSM549107patient 135, normal, homogenized [OPG study]4.9530340
GSM549115patient 068, normal, homogenized [OPG study]5.2572946
GSM549116patient 072, normal, homogenized [OPG study]5.0900443
GSM549120patient 078, normal, homogenized [OPG study]5.1245643
GSM549131patient 030, cancer, homogenized [OPG study]5.128444
GSM549118patient 074, normal, homogenized [OPG study]5.1517443
GSM549129patient 027, cancer, homogenized [OPG study]5.1352743
GSM549123patient 088, normal, homogenized [OPG study]4.9739240
GSM549124patient 006, cancer, homogenized [OPG study]5.0818941
GSM549126patient 015, cancer, homogenized [OPG study]5.2143245
GSM549128patient 025, cancer, homogenized [OPG study]4.9539540
GSM549103patient 117, normal, homogenized [OPG study]5.2712844
GSM549117patient 073, normal, homogenized [OPG study]5.0442142
GSM549138patient 041, cancer, homogenized [OPG study]5.0803242
GSM549141patient 045, cancer, homogenized [OPG study]4.9372840
GSM549130patient 028, cancer, homogenized [OPG study]5.0730842
GSM549101patient 111, normal, homogenized [OPG study]5.2951845
GSM549105patient 128, normal, homogenized [OPG study]5.1160942
GSM549106patient 134, normal, homogenized [OPG study]5.1106243
GSM549112patient 048, normal, homogenized [OPG study]4.9977640
GSM549125patient 011, cancer, homogenized [OPG study]5.114742
GSM549127patient 024, cancer, homogenized [OPG study]5.1199643
GSM549135patient 035, cancer, homogenized [OPG study]4.8886239